Findings

What do systematic reviews say?

7 questions · 7 findings · 4 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 14.3%GRADE not reported 1 · 14.3%Very low 0 · 0%Low 1 · 14.3%Moderate 3 · 42.9%High 1 · 14.3%

Celecoxib vs placebo

Pain · patients with osteoarthritis

1 finding from 1 review

Celecoxib for osteoarthritis 2017 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1622 participants
High

Celecoxib vs tNSAIDs

Pain · patients with osteoarthritis

1 finding from 1 review

Celecoxib for osteoarthritis 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1180 participants
Moderate

Celecoxib vs NSAIDs

Pain A 0 t o 100 visual or numerical scale, where 0 equals no pain at all and 100 is the worst pain imaginable · patients with rheumatoid arthritis

1 finding from 1 review

Celecoxib for rheumatoid arthritis 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1504 participants
Moderate

Celecoxib vs placebo

Pain A 0 t o 100 visual or numerical scale, where 0 equals no pain at all and 100 is the worst pain imaginable · patients with rheumatoid arthritis

1 finding from 1 review

Celecoxib for rheumatoid arthritis 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 706 participants
Moderate

Celecoxib vs naproxen

Participant‐reported pain relief of 30% or greater · children and adolescents with chronic non‐cancer pain

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 242 participants
Low

Celecoxib vs naproxen

Participant‐reported pain relief of 50% or greater · children and adolescents with chronic non‐cancer pain

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oral celecoxib (COX-2 inhibitor) vs placebo

Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…

Oral celecoxib (COX-2 inhibitor) showed no clear difference in pain intensity (VAS) compared with placebo; GRADE not reported.

1 finding from 1 review

Pharmacological interventions for pain in patients with temporomandibular disorders 2010 · Cochrane All outcomes
6 weeks
MD 0.03 [-0.40, 0.45]
1 study · 68 participants
GRADE not reported